Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006 (Under Co-payment Data Collection) Instrument 2012 (No. R21/2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L00745

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
Australian Government
Australian Participants in British Nuclear Tests (Treatment) Act 2006
 
Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006 (Under Co-payment Data Collection) Instrument 2012
Instrument No. R21/2012
I, Warren Snowdon, Minister for Veterans’ Affairs, pursuant to subsection 18(5) of the Australian Participants in British Nuclear Tests (Treatment) Act 2006, approve this instrument made by the Repatriation Commission.
 
Dated this       30th      day of              March  2012
Warren Snowdon
.................................................................................
WARREN SNOWDON
 
The Repatriation Commission, pursuant to subsection 18(4) of the Australian Participants in British Nuclear Tests (Treatment) Act 2006, varies the Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006 (Instrument No.R33 of 2006), in accordance with the Schedule.
Dated this       29th      day of              March  2012
Ian Campbell……………………… ……..…Shane Carmody………
IAN CAMPBELL                                                         SHANE CARMODY         
         psm                                                                                              
PRESIDENT                                                               DEPUTY PRESIDENT                         
 
 
 
[1]     Name of Instrument
This instrument is the Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006 (Under Co-payment Data Collection) Instrument 2012.
 
[2]  Commencement
 
This instrument commences on 1 April 2012.
 
 
 
Schedule
 
1.       Paragraph 3 (Part 1 - Interpretation)
 
insert:
 
approved supplier has the meaning given in Part VII of the National Health Act 1953.
 
Scheme means the Repatriation Pharmaceutical Benefits Scheme (Australian Participants in British Nuclear Tests) 2006.
Secretary has the meaning given in Part 1 of the National Health Act 1953.
 
2.      Part 5
 
after this Part, insert:
Part 5A — Under Co-payment Data Collection
32A.    Giving information
(1)     A Community Pharmacist who gives information to the Secretary in relation to the supply, under the Scheme, of a Pharmaceutical benefit by the pharmacist to an Eligible Person, is taken to have given that information under, and for the purposes of, the Scheme, provided that:
 
(a) no claim for payment is made by the Community Pharmacist on the Commission or Department for dispensing the Pharmaceutical benefit; and
 
(b) the dispensing price of the pharmaceutical benefit is less than, or equal to, the co-payment that would have been paid by the Eligible Person for the pharmaceutical benefit if it had been dispensed at a price for which a co-payment is payable; and
 
(c) the information is given in accordance with the requirements, to the extent applicable, that apply under section 98C of the National Health Act 1953 to an approved supplier giving information to the Secretary in relation to the supply to a person of a pharmaceutical benefit, as if references in section 98C to an approved supplier and a pharmaceutical benefit are references to, respectively, a Community Pharmacist and a Pharmaceutical benefit and the pharmaceutical benefit has been supplied under the Scheme.
 
Note: a Community Pharmacist includes an Approved Hospital Authority.